Medtronic bought the pain company to expand in neuromodulation, one of its areas of strategic focus and investment.
Source: MedTech Dive
You may also like
Trump’s CDC Nominee Praises Vaccines, Without Vowing...
Watch: ‘Robust’ Primary Care, Transparency Top...
Insurers Hedge on Trump-Backed Pledge To Improve...
Intuitive ties Q2 procedure softness to ACA subsidy...
Doc pay, price transparency on Congress’ healthcare...
Senate Republicans kill bid to end Medicare prior...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.